Related Experiment Video
Updated: May 18, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Alkyl hydroxybenzoic acid derivatives that inhibit HIV-1 protease dimerization
O A Flausino1, L Dufau, L O Regasini
1Enzymologie Moléculaire et Fonctionnelle, UR4, UPMC-Sorbonne Universités, 7 Quai St Bernard, 75252 Paris Cedex 05, France.
Current Medicinal Chemistry
|September 12, 2012
Summary
Gallic acid derivatives inhibit HIV-1 protease by disrupting enzyme dimerization, not active sites. Longer alkyl chains enhance inhibition, aiding new drug design for multi-mutated proteases.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Structural Biology
Background:
- Gallic acid and derivatives show promise as anti-cancer, antimicrobial, and antiviral agents.
- HIV-1 protease is a critical target for antiviral therapies.
- Understanding inhibition mechanisms is key for developing effective drugs.
Purpose of the Study:
- To investigate how gallic acid and related compounds inhibit HIV-1 protease.
- To compare the effects of aromatic ring substitutions and alkyl chain length on inhibition.
- To elucidate the mechanism of protease inhibition by these compounds.
Main Methods:
- Kinetic analysis (Zhang-Poorman method)
- Fluorescent probe binding assays
- Molecular dynamics simulations
Main Results:
- Gallic and protocatechuic acid alkyl esters inhibited HIV-1 protease by preventing enzyme dimerization.
- Inhibition efficacy depended on alkyl chain length (≥8 carbons) and aromatic substitution (tri-hydroxy favored).
- Molecular dynamics revealed esters intercalate between enzyme monomers, disrupting the dimer interface.
Conclusions:
- Gallic acid derivatives can inhibit HIV-1 protease by targeting dimerization, offering a novel therapeutic strategy.
- The findings support the rational design of non-peptide inhibitors for multi-mutated HIV-1 protease.
- Gallic and protocatechuic alkyl esters may be useful for dissociating protein-protein interactions involving beta-sheets.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.